132 related articles for article (PubMed ID: 27408879)
1. Production, biodistribution assessment and dosimetric evaluation of (177)Lu-TTHMP as an agent for bone pain palliation.
Zolghadri S; Yousefnia H; Jalilian AR; Ghannadi-Maragheh M
Asia Ocean J Nucl Med Biol; 2015; 3(1):35-42. PubMed ID: 27408879
[TBL] [Abstract][Full Text] [Related]
2. (175)Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals.
Safarzadeh L
Indian J Nucl Med; 2014 Jul; 29(3):135-9. PubMed ID: 25210277
[TBL] [Abstract][Full Text] [Related]
3. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
4. Production, quality control, biodistribution assessment and preliminary dose evaluation of (177)Lu-PDTMP as a possible bone palliative agent.
Yousefnia H; Jalilian AR; Zolghadri S; Ghannadi-Maragheh M
Nucl Med Commun; 2014 Jan; 35(1):99-107. PubMed ID: 24162837
[TBL] [Abstract][Full Text] [Related]
5. Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats.
Yousefnia H; Zolghadri S; Jalilian AR
J Med Phys; 2015; 40(2):102-8. PubMed ID: 26170557
[TBL] [Abstract][Full Text] [Related]
6. Production, Quality Control and Pharmacokinetic Studies of (177)Lu-EDTMP for Human Bone Pain Palliation Therapy Trials.
Bahrami-Samani A; Anvari A; Jalilian AR; Shirvani-Arani S; Yousefnia H; Aghamiri MR; Ghannadi-Maragheh M
Iran J Pharm Res; 2012; 11(1):137-44. PubMed ID: 25317195
[TBL] [Abstract][Full Text] [Related]
7. Estimation of human absorbed dose for (166)Ho-PAM: comparison with (166)Ho-DOTMP and (166)Ho-TTHMP.
Vaez-Tehrani M; Zolghadri S; Yousefnia H; Afarideh H
Br J Radiol; 2016 Oct; 89(1066):20160153. PubMed ID: 27524266
[TBL] [Abstract][Full Text] [Related]
8. Production, quality control, and determination of human absorbed dose of no carrier added
Salek N; Mehrabi M; Shirvani Arani S; Bahrami Samani A; Erfani M; Vosoghi S; Ghannadi Maragheh M; Shamsaei M
J Labelled Comp Radiopharm; 2017 Jan; 60(1):20-29. PubMed ID: 27862203
[TBL] [Abstract][Full Text] [Related]
9. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
10. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
[TBL] [Abstract][Full Text] [Related]
11. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
[TBL] [Abstract][Full Text] [Related]
12. Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation.
Salek N; Shamsaei M; Ghannadi Maragheh M; Shirvani Arani S; Bahrami Samani A
J Appl Clin Med Phys; 2016 Nov; 17(6):128-139. PubMed ID: 27929488
[TBL] [Abstract][Full Text] [Related]
13. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.
Máthé D; Balogh L; Polyák A; Király R; Márián T; Pawlak D; Zaknun JJ; Pillai MR; Jánoki GA
Nucl Med Biol; 2010 Feb; 37(2):215-26. PubMed ID: 20152721
[TBL] [Abstract][Full Text] [Related]
14. Studies on the Labeling of Ethylenediaminetetramethylene Phosphonic Acid, Methylene Diphosphonate, Sodium Pyrophosphate and Hydroxyapatite with Lutetium-177 for use in Nuclear Medicine.
Abbasi IA
World J Nucl Med; 2015; 14(2):95-100. PubMed ID: 26097419
[TBL] [Abstract][Full Text] [Related]
15. Preliminary dosimetric evaluation of (166)Ho-TTHMP for human based on biodistribution data in rats.
Yousefnia H; Zolghadri S; Jalilian AR; Tajik M; Ghannadi-Maragheh M
Appl Radiat Isot; 2014 Dec; 94():260-265. PubMed ID: 25255303
[TBL] [Abstract][Full Text] [Related]
16. Human Absorbed Dose Evaluation of [177Lu]Lu-IBA as a Bone Palliative Candidate.
Ranjbar H; Pourhabib Z
Nuklearmedizin; 2021 Oct; 60(5):375-380. PubMed ID: 34102691
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and post-therapy dosimetric analysis of [
Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
EJNMMI Res; 2019 Nov; 9(1):102. PubMed ID: 31781962
[TBL] [Abstract][Full Text] [Related]
18. Preparation, quality control and biodistribution assessment of ¹⁵³Sm-BPAMD as a novel agent for bone pain palliation therapy.
Rabie A; Enayati R; Yousefnia H; Jalilian AR; Shamsaei M; Zolghadri S; Bahrami-Samani A; Hosntalab M
Ann Nucl Med; 2015 Dec; 29(10):870-6. PubMed ID: 26260999
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Ready to Use Kit Formulation of EDTMP for the Preparation of 177Lu-EDTMP as a Bone Palliation Radiopharmaceutical.
Mercanoglu G; Zilbeyaz K; Arslan N
Curr Radiopharm; 2023; 16(1):38-43. PubMed ID: 35899954
[TBL] [Abstract][Full Text] [Related]
20. Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical.
Fathi F; Moghaddam-Banaem L; Shamsaei M; Samani A; Maragheh MG
J Med Phys; 2015; 40(3):156-64. PubMed ID: 26500402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
